EXPRESS SCRIPTS RIGHT PRICE
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

EXPRESS SCRIPTS RIGHT PRICE Trademark

Serial Number: 97115840

EXPRESS SCRIPTS RIGHT PRICE is a trademark filed by EXPRESS SCRIPTS STRATEGIC DEVELOPMENT, INC. on November 9, 2021. The trademark is classified under Class 36 (Insurance & Financial), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

EXPRESS SCRIPTS STRATEGIC DEVELOPMENT, INC. (287 trademarks)

ONE EXPRESS WAY
ST. LOUIS, MO 63121

Entity Type: 03

Trademark Details

Filing Date

November 9, 2021

Registration Date

Not Registered

Goods & Services

Prescription drug savings services relating to employer's self-funded prescription programs to provide claim surveillance to identify high cost generic, brand and specialty prescription drugs and provide alternate ways to reduce or eliminate drug costs; Pharmaceutical benefit management services; providing healthcare benefits optimization information; Providing financial consultation services in the field of pharmaceutical benefit optimization; Financial administration of pharmacy reimbursements programs and services

Cost management for prescription drug plans of others in the field of pharmaceuticals; business services, namely, prescription drug formulary cost management services; business administration of pharmacy reimbursement program and services; providing pharmaceutical, medication, drug, and healthcare information to physicians and pharmacists regarding costs related to the use of generic and name brand products of others; Business consulting services regarding healthcare costs, benefits and pharmacy services; Drug utilization review services; pharmaceutical cost management services; strategic business analysis and business advice regarding pharmacy benefit management, pharmaceutical end-user behavior, healthcare use behavior; market study and analysis of healthcare, healthcare benefits, and pharmacy benefits effecting health behavior change and choice at the patient level; market analysis and reporting of the effectiveness of tailored health messaging and support at the patient level; providing information in the field of pharmaceutical cost management as provided to pharmacy benefit management services clients, consultants and brokers

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jul 21, 2023 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Jul 21, 2023 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jul 21, 2023 ABN2
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 6, 2023 GNFN
FINAL REFUSAL E-MAILED
Apr 6, 2023 GNFR
FINAL REFUSAL WRITTEN
Apr 6, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 28, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 27, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 27, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 27, 2022 GNRN
NON-FINAL ACTION E-MAILED
Aug 27, 2022 GNRT
NON-FINAL ACTION WRITTEN
Aug 27, 2022 CNRT
ASSIGNED TO EXAMINER
Aug 19, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 17, 2021 NWOS
NEW APPLICATION ENTERED
Nov 12, 2021 NWAP